Evidence map›Paper›PMID 34787360›Full record

ArticleJournal of applied clinical medical physics2021

Adaptive radiation therapy strategies in the treatment of prostate cancer patients using hypofractionated VMAT.

Pawel Siciarz, Boyd McCurdy, Nikesh Hanumanthappa, Eric Van Uytven

Open access · goldAbstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Pawel SiciarzDepartment of Medical Physics, CancerCare Manitoba, Winnipeg, Manitoba, Canada.ORCID https://orcid.org/0000-0002-7953-7729
Boyd McCurdyDepartment of Medical Physics, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Nikesh HanumanthappaDepartment of Medical Physics, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Eric Van UytvenDepartment of Medical Physics, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
CancerCare Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo perform a comprehensive evaluation of eight adaptive radiation therapy strategies in the treatment of prostate cancer patients who underwent hypofractionated volumetric modulated arc therapy (VMAT) treatment. MATERIAL AND

methodsThe retrospective study included 20 prostate cancer patients treated with 40 Gy total dose over five fractions (8 Gy/fraction) using VMAT. Daily cone beam computed tomography images were acquired before the delivery of every fraction and then, with the application of deformable image registration used for the estimation of daily dose, contouring and plan re-optimization. Dosimetric benefits of the various ART strategies were quantified by the comparison of dose and dose-volume metrics derived from treatment planning objectives for original treatment plan and adapted plans with the consideration of target volumes (PTV and CTV) as well as critical structures (bladder, rectum, left, and right femoral heads).

resultsPercentage difference (ΔD) between planning objectives and delivered dose in the D

conclusionsDaily on-line adaptation approaches were the most advantageous, although strategies adapting every other fraction were also impactful while reducing relative workload as well. Offline treatment adaptations were shown to be less beneficial due to increased dose delivered to bladder and rectum compared toother ART strategies.

Indexed as

Prostatic NeoplasmsRadiotherapy, Intensity-ModulatedHumansMaleRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRetrospective Studiesadaptive radiation therapydeformable image registrationhypofractionationoffline plan adaptationonline plan adaptationprostate cancerVMAT

Identifiers

PMID34787360
PMCPMC8664140
OpenAlexW3213020083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.